Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Sci Rep ; 10(1): 20848, 2020 11 30.
Article in English | MEDLINE | ID: covidwho-951959

ABSTRACT

The emergence of the SARS-CoV-2 virus and subsequent COVID-19 pandemic initiated intense research into the mechanisms of action for this virus. It was quickly noted that COVID-19 presents more seriously in conjunction with other human disease conditions such as hypertension, diabetes, and lung diseases. We conducted a bioinformatics analysis of COVID-19 comorbidity-associated gene sets, identifying genes and pathways shared among the comorbidities, and evaluated current knowledge about these genes and pathways as related to current information about SARS-CoV-2 infection. We performed our analysis using GeneWeaver (GW), Reactome, and several biomedical ontologies to represent and compare common COVID-19 comorbidities. Phenotypic analysis of shared genes revealed significant enrichment for immune system phenotypes and for cardiovascular-related phenotypes, which might point to alleles and phenotypes in mouse models that could be evaluated for clues to COVID-19 severity. Through pathway analysis, we identified enriched pathways shared by comorbidity datasets and datasets associated with SARS-CoV-2 infection.


Subject(s)
COVID-19/mortality , COVID-19/pathology , Computational Biology/methods , Animals , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/genetics , Comorbidity , Cytokine Release Syndrome/mortality , Databases, Genetic , Diabetes Mellitus/epidemiology , Diabetes Mellitus/genetics , Disease Models, Animal , Hepatitis/epidemiology , Hepatitis/genetics , Humans , Kidney Diseases/epidemiology , Kidney Diseases/genetics , Lung Diseases/epidemiology , Lung Diseases/genetics , Mice , Respiratory Distress Syndrome/mortality , SARS-CoV-2 , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL